News

The approval from the drug regulator covers adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.

The study has demonstrated enhanced PFS in patients treated with talazoparib compared against patients who received physician’s choice standard of care chemotherapy. Talazoparib is an investigational, oral and

NICE recommends lenvatinib, also known as kisplyx, be given in conjunction with another drug called everolimus. This drug-duo is recommended as an option for people who have previously

AP-002 is a nasally inhaled surfactant based on a combination of Lyomark's Alveofact® (bovine lung surfactant) and Aerogen's next generation "PDAP™" delivery technology.  The partners expect AP-002 to

Ramucirumab, which is an antiangiogenic therapy, was evaluated in combination with cisplatin and capecitabine or 5-FU (5-fluorouracil) for the treatment of HER2-negative metastatic gastric or gastroesophageal junction (GEJ)

The study demonstrated that the Tecentriq combination has more effectively reduced the disease progression in patients compared to those who received Avastin plus chemotherapy. IMpower150 is a multicenter,

Cryotherapy is the general utilization of low temperatures in therapeutic treatment. It is utilized to cure a range of favorable and threatening tissue break, medically called as sores.

The companies will work together to advance TC BioPharm’s lead CAR-engineered gamma delta T cell program into clinical trials as well as on additional hematologic and solid tumor

Based in Emeryville, California, Cell Design Labs is a pre-clinical stage company, focused on developing disruptive CAR-T and T cell receptor (TCR) therapies to advance discovery and development